Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs

29 Nov 2023

Abstract excerpt

variants elevate risk, most HGSC cases occur in individuals without known genetic variants, necessitating prevention strategies for people without known high-risk genetic variants. Effective prevention programs are also needed due to the lack of traditional screening options. An emerging primary prevention strategy is opportunistic salpingectomy, which involves removing fallopian tubes during another planned...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Endometrial and Cervical Cancer Treatments
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38132375
DOI: 10.3390/curroncol30120741

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention ProgramsPMID 38132375Read ↗

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?Semantic proximity Read ↗

Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution.Semantic proximity Read ↗

Ovarian Cancer Prevention and Screening.Semantic proximity Read ↗

Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.Semantic proximity Read ↗

Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.Semantic proximity Read ↗

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.Semantic proximity Read ↗

Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.Semantic proximity Read ↗

Epithelial ovarian cancer risk: A review of the current genetic landscapeSemantic proximity Read ↗

Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for PreventionSemantic proximity Read ↗

Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.